Become A Featured Company

Cannabis Legalization Linked to Increase in Fatal Motor Vehicle Collisions

Ryan Allway

October 6th, 2021

News, Top Story

Most people that have used recreational cannabis know of its mind-altering effects. So, it shouldn’t come as a surprise that driving under the influence of marijuana can at least disrupt traffic and, at worst, lead to an increase in fatal motor vehicle collisions. A recent study published in the Canadian Medical Association Journal confirmed these suspicions.

Let’s take a look at recent studies showing a troubling trend and some solutions to the problem, including Cannabix Technologies Inc.’s (CSE: BLO, OTC: BLOZF) unique FAIMS-based breathalyzer technology.

An Increase in Fatal Accidents

The study, “Impaired Driving and Legalization of Recreational Cannabis,” sought to explore the link between cannabis legalization and fatal motor vehicle collisions across the United States and Canada. The authors found a small but significant increase in fatal motor vehicle collisions and fatalities, resulting in as many as 308 excess deaths in Canada.

With 13% of cannabis users reporting driving within two hours of cannabis consumption, driving under the influence is a significant problem that will continue to grow as more and more people consume legal cannabis products. In Canada, the number of people reporting cannabis consumption rose from 14% in 2018 to 17% in 2019.

Of course, non-fatal collisions and dangerous driving have their own costs. For example, an analysis of 2012 data found that the cost of cannabis-related crashes in Canada exceeds $1 billion per year when factoring in societal and economic costs. And drivers aged 34 years and younger were responsible for the bulk of these costs.

In the U.S., research from the IIHS and HLDI added more evidence to the assertion that cannabis legalization leads to an increase in crash rates. The most recent study from the group found an increase in injury and fatal crash rates in California, Colorado, Nevada, Oregon, and Washington in the months following the relaxation of marijuana laws.

Finding an Answer for Safer Roads

Government regulations and public awareness are crucial to reducing the risk of injury or death from driving after cannabis use. But, of course, enforcement also plays a vital role in deterring cannabis users from getting in the driver’s seat. The fear of a ticket or arrest is often enough to discourage people while revoking the licenses of unsafe drivers.

Unfortunately, THC is metabolized differently than alcohol by the human body, making it hard to detect. The good news is that companies like Cannabix Technologies Inc. (CSE: BLO, OTC: BLOZF) are developing innovative technologies that address this major challenge.

The Cannabix FAIMS Device – Source: Cannabix Technologies

Cannabix’s high-field asymmetric waveform ion mobility spectrometry (“FAIMS”) breath detection system is being developed to detect THC in breath to selectively detect recent marijuana use at the point of care. This kind of device would be an ideal drug screening tool to aid law enforcement and other markets.

What’s Next?

Cannabis rules and regulations are only starting to solidify after legalization trends swept both Canada and the United States. While governments are finally beginning to set legal limits, law enforcement still requires technology to detect recent consumption accurately and provide scientific evidence and hold drivers responsible. This is a significant market opportunity for the Company.

Cannabix Technologies Inc. (CSE: BLO, OTC: BLOZF) has been leading the way in developing these technologies to enhance public safety.  By providing a relevant and convenient roadside testing solution, Cannabix is working to give law enforcement and employers the tools they currently lack to accurately determine recent marijuana use at the point of care. Combined with continued public education, such a tool could clear up a lot of the grey areas currently surrounding the issue of driving under the influence of cannabis and help keep our roads safer.

Visit the company’s website or to learn more.

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading